Sunshine SwissCo GmbH, a consortium led by EQT, has completed an accelerated bookbuilding process aimed at professional investors in Switzerland and qualified investors abroad, resulting in the placement of 15 million shares in Galderma.
The shares were priced at CHF 89 each, generating total gross proceeds of CHF 1,335 million. The placement does not affect EQT’s representation on Galderma’s board of directors. The selling shareholders have agreed to a 90-day lock-up period, subject to customary exceptions, with regard to their remaining participation in Galderma.
The banking syndicate in the transaction consisted of Bank of America, BNP Paribas, Goldman Sachs, Morgan Stanley and UBS.